BVNRY Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:20):

Stats
Šios dienos apimtis	892.00
Vidutinė apimtis	5 243.00
Rinkos kapitalizacija	1.65B
EPS	$0 ( 2024-03-07 )
Kita pelno data	( $0 ) 2024-05-14
Last Dividend	$0.593 ( 2020-03-27 )
Next Dividend	$0 ( N/A )
P/E	7.66
ATR14	$0 (0.00%)

Bavarian Nordic A/S Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Bavarian Nordic A/S Finansinės ataskaitos

Annual	2023
Pajamos:	$7.06B
Bruto pelnas:	$4.52B (64.07 %)
EPS:	$19.23

FY	2023
Pajamos:	$7.06B
Bruto pelnas:	$4.52B (64.07 %)
EPS:	$19.23

FY	2023
Pajamos:	$0
Bruto pelnas:	$0 (0.00 %)
EPS:	$0

FY	2022
Pajamos:	$3.15B
Bruto pelnas:	$1.70B (53.99 %)
EPS:	$-4.93

Financial Reports:

No articles found.

Bavarian Nordic A/S Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Bavarian Nordic A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.34 - Potential for dividend initiation, but uncertain (13.19%)

Information

First Dividend	$0.593	2020-03-27
Last Dividend	$0.593	2020-03-27
Next Dividend	$0	N/A
Payout Date	2020-04-06
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.593	--
Avg. Dividend % Per Year	0.00%	--
Score	2.27	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.34
Div. Directional Score	7.53	--

Next Divdend (Est)
(2024-04-27)

$0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

2.27

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SCGLY	Ex Dividend Junior	2023-05-25	Annually	0.00%
FSUGY	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
AGESY	Ex Dividend Junior	2023-10-25	Annually	0.00%
YATRF	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
MONDY	Ex Dividend Knight	2023-08-24	Semi-Annually	0.00%
CNLTP	Ex Dividend Knight	2023-07-07	Quarterly	0.00%
STBI	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
HKXCY	Ex Dividend Knight	2023-08-28	Semi-Annually	0.00%
ASBFY	Ex Dividend Knight	2023-06-01	Annually	0.00%
OLCLF	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.209	1.500	5.82	8.74	[0 - 0.5]
returnOnAssetsTTM	0.103	1.200	6.57	7.89	[0 - 0.3]
returnOnEquityTTM	0.153	1.500	9.41	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.938	0.800	5.31	4.25	[1 - 3]
quickRatioTTM	1.342	0.800	6.81	5.45	[0.8 - 2.5]
cashRatioTTM	0.530	1.500	8.17	10.00	[0.2 - 2]
debtRatioTTM	0.00430	-1.500	9.93	-10.00	[0 - 0.6]
interestCoverageTTM	25.16	1.000	1.793	1.793	[3 - 30]
operatingCashFlowPerShareTTM	14.59	2.00	5.14	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.849	2.00	9.08	10.00	[0 - 20]
debtEquityRatioTTM	0.00597	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.652	1.000	2.47	2.47	[0.2 - 0.8]
operatingProfitMarginTTM	0.215	1.000	7.70	7.70	[0.1 - 0.6]
cashFlowToDebtRatioTTM	18.15	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.492	0.800	-0.0521	-0.0416	[0.5 - 2]
Total Score				10.72

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	2.55	1.000	9.84	0	[1 - 100]
returnOnEquityTTM	0.153	2.50	9.62	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.849	2.00	9.38	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	14.59	2.00	5.14	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00228	1.500	-3.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.158	1.000	8.54	0	[0.1 - 0.5]
Total Score				4.34

Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. The company operates in the United States, Belgium, Germany, the Netherlands, Sweden, Switzerland, Austria, the United Kingdom, Japan, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.